Clinical trial
Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver…
NCT00025415 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00025415 |
|---|---|
| Title | Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction |
| Official title | A Phase I Pharmacokinetic Study of STI571 in Patients With Advanced Malignancies and Varying Levels of Liver Dysfunction |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Myelodysplastic Syndromes and 76 more |
| Intervention type | Drug, Other |
| Interventions | imatinib mesylate, pharmacological study |
| Enrollment | 60 |
| Start date | Aug 1, 2001 |
| Primary completion | Jan 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 7, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: